Financials InterCure Ltd.

Equities

INCR

IL0011063760

Healthcare Facilities & Services

Delayed TEL AVIV STOCK EXCHANGE 10:04:54 15/05/2024 BST 5-day change 1st Jan Change
1,166 ILa -1.85% Intraday chart for InterCure Ltd. -6.04% +151.78%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 417.5 404.1 440.5 932.3 550.5 211
Enterprise Value (EV) 1 426.6 393.6 407.6 844.6 572.9 305.4
P/E ratio -31.6 x -124 x -11.2 x 207 x 12.2 x -3.41 x
Yield - - - - - -
Capitalization / Revenue - 45,271,664 x 6,773,655 x 4,243,845 x 1,416,365 x 593,574 x
EV / Revenue - 44,099,358 x 6,268,065 x 3,844,919 x 1,473,908 x 858,938 x
EV / EBITDA -42.1 x -4.96 x 286 x 23.8 x 11.9 x 45.7 x
EV / FCF 161 x -18.4 x -33 x 116 x -12.3 x -5.23 x
FCF Yield 0.62% -5.44% -3.03% 0.86% -8.16% -19.1%
Price to Book 21.2 x 1.58 x 1.6 x 2.09 x 1.1 x 0.46 x
Nbr of stocks (in thousands) 18,548 24,382 26,942 44,994 45,573 45,573
Reference price 2 22.51 16.57 16.35 20.72 12.08 4.631
Announcement Date 01/04/19 30/04/20 31/03/21 05/04/22 31/03/23 01/05/24
1ILS in Million2ILS
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - 8.926 65.04 219.7 388.7 355.6
EBITDA 1 -10.12 -79.4 1.425 35.53 48.34 6.681
EBIT 1 -10.13 -79.98 -1.205 30.41 40.85 -1.503
Operating Margin - -896.06% -1.85% 13.84% 10.51% -0.42%
Earnings before Tax (EBT) 1 -12.8 -3.669 -38.31 18.74 43.84 -61.28
Net income 1 -12.8 -2.996 -37.23 4.692 44.82 -61.96
Net margin - -33.56% -57.25% 2.14% 11.53% -17.43%
EPS 2 -0.7125 -0.1335 -1.466 0.1000 0.9882 -1.360
Free Cash Flow 1 2.649 -21.4 -12.36 7.275 -46.73 -58.34
FCF margin - -239.8% -19% 3.31% -12.02% -16.41%
FCF Conversion (EBITDA) - - - 20.48% - -
FCF Conversion (Net income) - - - 155.04% - -
Dividend per Share - - - - - -
Announcement Date 01/04/19 30/04/20 31/03/21 05/04/22 31/03/23 01/05/24
1ILS in Million2ILS
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 19.89 26.39 25.71 29.28 29.5 29.42 28.99 26.94
EBITDA 1 - 7.197 6.278 6.796 5.764 5.161 - 2.988
EBIT 1 2.308 2.831 4.924 4.835 4.12 2.271 1.841 1.321
Operating Margin 11.6% 10.73% 19.15% 16.51% 13.96% 7.72% 6.35% 4.9%
Earnings before Tax (EBT) 1 0.6695 0.7974 5.72 6.475 3.504 -2.43 0.4844 0.106
Net income 1 -0.53 -0.9567 3.942 4.689 2.128 2.382 0.0584 1.284
Net margin -2.66% -3.63% 15.33% 16.01% 7.21% 8.1% 0.2% 4.77%
EPS - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 15/11/21 04/04/22 16/05/22 15/08/22 15/11/22 31/03/23 15/05/23 31/08/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 9.12 - - - 22.4 94.4
Net Cash position 1 - 10.5 32.9 87.6 - -
Leverage (Debt/EBITDA) -0.9003 x - - - 0.4627 x 14.12 x
Free Cash Flow 1 2.65 -21.4 -12.4 7.27 -46.7 -58.3
ROE (net income / shareholders' equity) -61.9% -2.17% -13.1% 1.94% 8.83% -13%
ROA (Net income/ Total Assets) -20.7% -31.4% -0.25% 3.75% 3.09% -0.11%
Assets 1 61.7 9.534 15,043 125 1,452 57,583
Book Value Per Share 2 1.060 10.50 10.20 9.930 11.00 9.990
Cash Flow per Share 2 0.1800 1.120 1.410 4.350 5.100 2.220
Capex 1 0.09 28.1 20.8 14 19.7 2.62
Capex / Sales - 315.3% 32.05% 6.39% 5.08% 0.74%
Announcement Date 01/04/19 30/04/20 31/03/21 05/04/22 31/03/23 01/05/24
1ILS in Million2ILS
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. INCR Stock
  4. Financials InterCure Ltd.